Cantel Medical Corp. (CMN) Releases Earnings Results, Beats Expectations By $0.08 EPS

Cantel Medical Corp. (CMN) reported quarterly earnings results on Wednesday, Jun-8-2016. The company said it had a profit of $0.44 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.08. Analysts had a consensus of $0.36. The company posted revenue of $173.70 million in the period, compared to analysts expectations of $163.16 million. The company’s revenue was up 22.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.35 EPS.

Cantel Medical Corp. opened for trading at $68.73 and hit $69.23 on the upside on Tuesday, eventually ending the session at $68.74, with a gain of 0.09% or 0.06 points. The heightened volatility saw the trading volume jump to 2,17,712 shares. Company has a market cap of $2,867 M.

In a different news, on Apr 15, 2016, Eric W Nodiff (EVP and General Counsel) sold 3,500 shares at $70.42 per share price. According to the SEC, on Apr 5, 2016, Charles M Diker (Chairman) sold 10,000 shares at $71.78 per share price. On Dec 31, 2015, Andrew A Krakauer (CEO) sold 9,438 shares at $62.49 per share price, according to the Form-4 filing with the securities and exchange commission.

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy Water Purification and Filtration Healthcare Disposables Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems disinfectants detergents and other supplies. The Company’s Water Purification and Filtration segment includes water purification equipment and services filtration and separation products and disinfectants sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use infection prevention and control healthcare products. The Company’s Dialysis segment includes medical device reprocessing systems sterilants/disinfectants and dialysate concentrates. Its Specialty Packaging segment includes specialty packaging and thermal control products as well as related compliance training.

Cantel Medical Corp.

Leave a Reply

Cantel Medical Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cantel Medical Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.